-
2
-
-
33749618667
-
Palliation of malignant dysphagia in esophageal cancer: A literature-based review
-
379. Comments in: J Support Oncol 2006;4(8):377-379
-
Javle M., Ailawadhi S., Yang G.Y., et al. Palliation of malignant dysphagia in esophageal cancer: A literature-based review. J Support Oncol 4 (2006) 365-373 379. Comments in: J Support Oncol 2006;4(8):377-379
-
(2006)
J Support Oncol
, vol.4
, pp. 365-373
-
-
Javle, M.1
Ailawadhi, S.2
Yang, G.Y.3
-
3
-
-
33644532217
-
Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma
-
Yamada K., Murakami M., Okamoto Y., et al. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys 64 (2006) 1106-1111
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 1106-1111
-
-
Yamada, K.1
Murakami, M.2
Okamoto, Y.3
-
4
-
-
33745685652
-
Role of photodynamic therapy in unresectable esophageal and lung cancer
-
Chen M., Pennathur A., and Luketich J.D. Role of photodynamic therapy in unresectable esophageal and lung cancer. Lasers Surg Med 38 (2006) 396-402
-
(2006)
Lasers Surg Med
, vol.38
, pp. 396-402
-
-
Chen, M.1
Pennathur, A.2
Luketich, J.D.3
-
5
-
-
56149127251
-
Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy
-
Rades D., Golke H., Schild S.E., and Kilic E. Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy. Strahlenther Onkol 184 (2008) 416-420
-
(2008)
Strahlenther Onkol
, vol.184
, pp. 416-420
-
-
Rades, D.1
Golke, H.2
Schild, S.E.3
Kilic, E.4
-
6
-
-
33748530642
-
External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma
-
Pasquier D., Mirabel X., Adenis A., et al. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 1456-1461
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 1456-1461
-
-
Pasquier, D.1
Mirabel, X.2
Adenis, A.3
-
7
-
-
4544235327
-
Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer
-
Skowronek J., Piotrowski T., and Zwierzchowski G. Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer. Brachytherapy 3 (2004) 87-94
-
(2004)
Brachytherapy
, vol.3
, pp. 87-94
-
-
Skowronek, J.1
Piotrowski, T.2
Zwierzchowski, G.3
-
8
-
-
0141449138
-
Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: A 10-year experience
-
Goodman K.A., Wolden S.L., LaQuaglia M.P., et al. Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: A 10-year experience. Brachytherapy 2 (2003) 139-146
-
(2003)
Brachytherapy
, vol.2
, pp. 139-146
-
-
Goodman, K.A.1
Wolden, S.L.2
LaQuaglia, M.P.3
-
9
-
-
33645804046
-
JASTRO Study Group. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group
-
Nemoto K., Yamada S., Nishio M., et al. JASTRO Study Group. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Res 26 (2006) 1507-1512
-
(2006)
Anticancer Res
, vol.26
, pp. 1507-1512
-
-
Nemoto, K.1
Yamada, S.2
Nishio, M.3
-
10
-
-
10644267813
-
Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer
-
Sur R., Donde B., Falkson C., et al. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy 3 (2004) 191-195
-
(2004)
Brachytherapy
, vol.3
, pp. 191-195
-
-
Sur, R.1
Donde, B.2
Falkson, C.3
-
11
-
-
38149016257
-
Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost
-
Brunner T.B., Rupp A., Melzner W., Grabenbauer G.G., and Sauer R. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost. Strahlenther Onkol 184 (2008) 15-22
-
(2008)
Strahlenther Onkol
, vol.184
, pp. 15-22
-
-
Brunner, T.B.1
Rupp, A.2
Melzner, W.3
Grabenbauer, G.G.4
Sauer, R.5
-
12
-
-
34548392333
-
Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship
-
Levendag P.C., Teguh D.N., Voet P., et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother Oncol 85 (2007) 64-73
-
(2007)
Radiother Oncol
, vol.85
, pp. 64-73
-
-
Levendag, P.C.1
Teguh, D.N.2
Voet, P.3
-
13
-
-
0031128390
-
Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer
-
Gaspar L.E., Nag S., Herskovic A., et al. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Int J Radiat Oncol Biol Phys 38 (1997) 127-132
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.38
, pp. 127-132
-
-
Gaspar, L.E.1
Nag, S.2
Herskovic, A.3
-
14
-
-
33846427692
-
Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer
-
Rades D., Schulte R., Yekebas E.F., et al. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer. Strahlenther Onkol 183 (2007) 10-16
-
(2007)
Strahlenther Onkol
, vol.183
, pp. 10-16
-
-
Rades, D.1
Schulte, R.2
Yekebas, E.F.3
-
15
-
-
33645106395
-
Dutch SIREC Study Group. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer
-
Homs M.Y., Steyerberg E.W., Eijkenboom W.M., et al. Dutch SIREC Study Group. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer. Brachytherapy 5 (2006) 41-48
-
(2006)
Brachytherapy
, vol.5
, pp. 41-48
-
-
Homs, M.Y.1
Steyerberg, E.W.2
Eijkenboom, W.M.3
-
16
-
-
33846977069
-
Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer
-
Patonay P., Naszály A., and Mayer A. Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer. Strahlenther Onkol 183 (2007) 94-98
-
(2007)
Strahlenther Onkol
, vol.183
, pp. 94-98
-
-
Patonay, P.1
Naszály, A.2
Mayer, A.3
-
17
-
-
6944231389
-
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial
-
Homs M.Y., Steyerberg E.W., Eijkenboom W.M., et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial. Lancet 364 (2004) 1497-1504
-
(2004)
Lancet
, vol.364
, pp. 1497-1504
-
-
Homs, M.Y.1
Steyerberg, E.W.2
Eijkenboom, W.M.3
-
18
-
-
23944445341
-
Stent vs. brachytherapy: Does life expectancy help you decide?
-
Comment on: Gastrointest Endosc 2005;62:333-340
-
Wallace M.B. Stent vs. brachytherapy: Does life expectancy help you decide?. Gastrointest Endosc 62 (2005) 341-343 Comment on: Gastrointest Endosc 2005;62:333-340
-
(2005)
Gastrointest Endosc
, vol.62
, pp. 341-343
-
-
Wallace, M.B.1
-
19
-
-
55949125573
-
Cost-effectiveness of palliation of unresectable esophageal cancer
-
da Silveira E.B., and Artifon E.L. Cost-effectiveness of palliation of unresectable esophageal cancer. Dig Dis Sci 53 (2008) 3103-3111
-
(2008)
Dig Dis Sci
, vol.53
, pp. 3103-3111
-
-
da Silveira, E.B.1
Artifon, E.L.2
-
20
-
-
29144449888
-
Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial
-
Bergquist H., Wenger U., Johnsson E., et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 18 (2005) 131-139
-
(2005)
Dis Esophagus
, vol.18
, pp. 131-139
-
-
Bergquist, H.1
Wenger, U.2
Johnsson, E.3
-
22
-
-
77949659166
-
-
Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0 2006, Available at
-
Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0 (2006). Available at: http://ctep.cancer.gov.
-
-
-
-
23
-
-
0032533670
-
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
-
Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
-
(1998)
Cancer
, vol.83
, pp. 2049-2053
-
-
Devesa, S.S.1
Blot, W.J.2
Fraumeni Jr., J.F.3
-
24
-
-
0032756946
-
The changing epidemiology of esophageal cancer
-
Blot W.J., and McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 26 5 Suppl. 15 (1999) 2-8
-
(1999)
Semin Oncol
, vol.26
, Issue.5 SUPPL. 15
, pp. 2-8
-
-
Blot, W.J.1
McLaughlin, J.K.2
-
25
-
-
0030750319
-
Clinicopathological features of superficial squamous cell carcinoma of the esophagus
-
Tachibana M., Yoshimura H., Kinugasa S., et al. Clinicopathological features of superficial squamous cell carcinoma of the esophagus. Am J Surg 174 (1997) 49-53
-
(1997)
Am J Surg
, vol.174
, pp. 49-53
-
-
Tachibana, M.1
Yoshimura, H.2
Kinugasa, S.3
-
26
-
-
34147184160
-
Significance of radiation therapy for adenocarcinomas of the esophagus, gastroesophageal junction and gastric cancer with special reference to the MAGIC trial
-
Klautke G., and Fietkau R. Significance of radiation therapy for adenocarcinomas of the esophagus, gastroesophageal junction and gastric cancer with special reference to the MAGIC trial. Strahlenther Onkol 183 (2007) 163-169
-
(2007)
Strahlenther Onkol
, vol.183
, pp. 163-169
-
-
Klautke, G.1
Fietkau, R.2
|